Combined Tretinoin and Tranexamic Acid Cream for Hyperpigmentation After Electrosurgery
Effectiveness Of Combined Tretinoin and Tranexamic Acid Cream Compred With Tretinoin Cream Alone for Past-Electrosurgical Hyperpigmentation in Patients With Benign Skin Tumors.
This study aims to evaluate the effectiveness of a cream containing tretinoin and tranexamic acid compared with tretinoin cream alone in managing post-inflammatory hyperpigmentation following electrosurgery in patients with benign skin tumors. Post-inflammatory hyperpigmentation is a condition in which the skin becomes darker after inflammation or injury, including after certain dermatological procedures. This discoloration may affect patients' appearance and quality of life.
The study will compare two treatment groups: one receiving a combination of tretinoin and tranexamic acid cream and the other receiving tretinoin cream alone. Participants will undergo treatment for four weeks. The researchers will evaluate changes in skin pigmentation and skin barrier function using the Post-Inflammatory Hyperpigmentation Area and Severity Index (PIHASI), transepidermal water loss (TEWL), and skin hydration measurements.
The findings are expected to provide information about the potential benefits of combining tretinoin and tranexamic acid for managing hyperpigmentation after electrosurgery.
調査の概要
状態
研究の種類
入学 (推定)
段階
- フェーズ2
連絡先と場所
研究連絡先
- 名前:Wahyu Lestari, MD, PhD, Sp.DVE
- 電話番号:+628126991901
- メール:wahyu_lestari2000@usk.ac.id
研究連絡先のバックアップ
- 名前:Sarah Nabila
- 電話番号:+6285270340806
- メール:sarahnabila806@gmail.com
研究場所
-
-
Special Region of Aceh
-
Banda Aceh、Special Region of Aceh、インドネシア、24415
- 募集
- Dr. Zainoel Abidin Regional General Hospital
-
コンタクト:
- Wahyu Lestari, MD, PhD, Sp.DVE
- 電話番号:+628126991901
- メール:wahyu_lestari2000@usk.ac.id
-
コンタクト:
- Sarah Nabila
- 電話番号:+6285270340806
- メール:sarahnabila806@gmail.com
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- Adults aged 18 to 60 years.
- Patients diagnosed with benign skin tumors.
- Patients undergoing electrosurgical treatment.
- Patients willing to participate in the study from enrollment through completion and provide informed consent.
Exclusion Criteria:
- Pregnant women.
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:処理
- 割り当て:非ランダム化
- 介入モデル:並列代入
- マスキング:なし(オープンラベル)
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的:Experimental: Tretinoin and Tranexamic Acid Cream
Participants assigned to this group will receive a topical cream containing tretinoin and tranexamic acid following electrosurgery. The intervention will be administered according to the study protocol to evaluate changes in post-electrosurgical hyperpigmentation. |
A topical cream containing a combination of tretinoin and tranexamic acid will be administered to the designated treatment area following electrosurgery. The intervention is being investigated to evaluate its potential effect on post-electrosurgical hyperpigmentation. Changes in skin pigmentation will be assessed according to the study protocol to determine the observed response to treatment. |
|
アクティブコンパレータ:Active Comparator: Tretinoin Cream
Participants assigned to this group will receive topical tretinoin cream following electrosurgery. This group will serve as a comparator to assess differences in post-electrosurgical hyperpigmentation between the two treatment groups. |
Topical tretinoin cream will be administered to the designated treatment area following electrosurgery. This intervention will serve as the comparator for evaluating differences in post-electrosurgical hyperpigmentation between the treatment groups. |
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Change in Post-Inflammatory Hyperpigmentation Area and Severity Index (PIHASI) Score
時間枠:Baseline and Week 4
|
Changes in post-inflammatory hyperpigmentation will be assessed using the PIHASI score. Scores will be recorded before treatment and at the scheduled follow-up assessment to evaluate changes in pigmentation severity following the application of the study creams. |
Baseline and Week 4
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Change in Transepidermal Water Loss (TEWL)
時間枠:Baseline and Week 4
|
Transepidermal water loss will be measured to assess changes in skin barrier function from baseline to Week 4. |
Baseline and Week 4
|
|
Change in Skin Hydration
時間枠:Baseline and Week 4
|
Skin hydration will be measured to assess changes in skin moisture levels from baseline to Week 4. |
Baseline and Week 4
|
協力者と研究者
スポンサー
捜査官
- 主任研究者:Wahyu Lestari, MD, PhD, Sp.DVE、RSUD dr. Zainoel Abidin
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
追加の関連 MeSH 用語
その他の研究ID番号
- 124/ETIK-RSUDZA/2026
- 124/ETIK-RSUDZA/2026 (その他の識別子:Komite Etik Penelitian Kesehatan RSUD dr. Zainoel Abidin)
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。